Conference Channels
Recent Congresses and Workshops
Recent VJSession Roundtables
Upcoming Events
Archive
ALL Sessions
AML Sessions
Amyloidosis Sessions
American Society of Clinical Oncology
American Society of Hematology
Bing Center for Waldenstrom's Macroglobulinemia
British Society of Haematology (BSH) and International Society of Hematology (ISH)
Cellular Therapy Sessions
CLL Sessions
World Congress on Controversies in Multiple Myeloma
International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies
Deutscher Krebs Kongress
European Group for Blood and Marrow Transplantation
European Society for Blood & Marrow Transplantation (EBMT) and the European Hematology Association (EHA)
European Cancer Congress of the European Cancer Organisation
European Hematology Association
Eurasian Hematology-Oncology Group
European Multiple Myeloma Academy
European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF)
European School of Haematology
EuroCARTForce
International Workshop of the German CLL Study Group
HMP Oncology
Hematology/Oncology Pharmacy Association
International Academy for Clinical Hematology
Intercepting Blood Cancers
International Conference On Lymphocyte Engineering
International Society for Cellular Therapy
International Society of Hematology
International Symposium on Hodgkin Lymphoma
International Workshop on Acute Leukemias
International Workshop on CAR-T
International Workshop on CLL
International Workshop on Myelodysplastic Syndromes
International Workshop on Myeloproliferative Neoplasms
International Workshop on Myeloma
International Workshop on Non-Hodgkin Lymphoma
Leukemia, Lymphoma and Myeloma Center
Lymphoma Sessions
- Updates in CAR-T & bispecific antibodies from EHA 2023
- Key highlights in T-cell lymphoma from ASH 2022
- Key highlights in NHL from ASH 2022
- iwNHL 2022
- Key updates in lymphoma and impact on UK clinical practice
- Lymphoma updates from iwCAR-T 2022
- CAR-T and lymphoma treatment in the UK
- Post-ASH 2021
- Post-EHA/ICML 2021
- Post-ASH 2020 UK
- Post-ASH 2020
MDS Sessions
- Management of anemia in LR-MDS & overcoming treatment failure in HR-MDS
- Comparing the ICC and WHO classifications for MDS & their impact on clinical practice
- Key highlights from ASH 2022
- iwMDS 2022
- The impact of AI in MDS
- What did ASH 2021 mean for MDS?
- Post-EHA/ASCO 2021
- Women in Science
- Diagnosis & Prognosis
- Giants in MDS
- Global Perspectives
- Post-ASH 2020
- Lower-Risk Disease
- Latest Updates
Melton Medical Education
Multiple Myeloma Research Foundation
MPN Advances
MPN Sessions
International Congress on Myeloproliferative Neoplasms
Myeloma Sessions
- Key highlights from EHA 2023
- iwMyeloma 2023
- Key highlights from ASH 2022
- Updates from IMS 2022
- iwCAR-T 2022 day 3 highlights with a focus on myeloma
- Myeloma updates from EHA 2022
- Myeloma treatment in the UK
- PIKfyve, RAS, the epigenome & PROTAC therapy
- Novel targets in 2022
- Day 2 highlights from Myeloma 2022
- T-Cell engagers
- Day 1 highlights from Myeloma 2022
- Using single-cell analysis to tackle myeloma
- Genomics in the age of I-O
- Post-ASH 2021
- A deep dive into screening for precursor conditions
- Post-EHA/ASCO 2021
- The patient perspective
- Post-COMy 2021
- Post-ASH 2020
- Post-ASH 2020 UK
- Myeloma & COVID-19
- COMy & EHA 2020
Society of Immunotherapy for Cancer
Society of Hematologic Oncology Italy
Transplantation & Cellular Therapy
Texas MPN Workshop
The Myelodysplastic Syndromes Foundation
The University of Chicago
Transplant Sessions
UK Oncology Nursing Society
